Gerber, David E <br/><br/>
Calculated versus measured creatinine clearance for dosing methotrexate in the treatment of primary central nervous system lymphoma.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  May 2007 
 - 817-23 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/s00280-006-0339-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Central Nervous System Neoplasms--drug therapy<br/>Creatinine--pharmacokinetics<br/>Female<br/>Humans<br/>Kidney Function Tests--methods<br/>Lymphoma--drug therapy<br/>Male<br/>Metabolic Clearance Rate<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Retrospective Studies